WM
Wuhan More Biotechnology Co., Ltd
CDMO · Wuhan, China
Overview
Wuhan More Biotechnology (Morebio) was founded in 2008 in the East Lake High-Tech Zone and works on peptide drugs made by fermentation. It offers CDMO services and lists semaglutide, tirzepatide, liraglutide, retatrutide and cagrilintide among its generic APIs, plus proteases and cell therapy products. It holds active US Type II DMFs for semaglutide (039115) and semaglutide main chain (039480).
Capabilities
- Fermentation-based peptide APIs
- CDMO services
- Recombinant proteases
- Cell therapy products
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |